Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Treatment for Untreated Lyme Disease Diagnosed Through Bloodwork

Disease Staging and Treatment Selection

  • Untreated Lyme disease diagnosed through bloodwork should be treated with standard antibiotic therapy based on the stage of disease, with oral antibiotics for early disease and possibly parenteral antibiotics for later-stage manifestations, as recommended by the Centers for Disease Control and Prevention 1, 2
  • Oral antibiotics are the standard treatment for early uncomplicated Lyme disease, including cases with isolated cranial nerve palsy, with a recommended duration of 14-21 days 1, 3
  • For late manifestations such as arthritis, neurologic disease, or cardiac involvement, treatment depends on specific manifestations, with oral antibiotic therapy for 28 days recommended for Lyme arthritis 5, 4
  • Neurologic Lyme disease with CNS involvement requires intravenous antibiotics 6, 7
  • Lyme carditis can be treated with oral antibiotics in outpatients, while hospitalized patients may require initial IV ceftriaxone until clinical improvement, then switch to oral antibiotics, with a total treatment duration of 14-21 days 5, 7, 4

Specific Antibiotic Recommendations

  • The Infectious Diseases Society of America recommends doxycycline 100mg twice daily, amoxicillin 500mg three or four times daily, and cefuroxime axetil as first-line oral regimens for early disease 2
  • The American College of Rheumatology recommends a duration of 14-21 days for early disease and 28 days for Lyme arthritis 2, 5

Important Clinical Considerations

  • Most patients respond well to appropriate antibiotic therapy, with a treatment failure rate of approximately 1% 1, 2
  • Late, complicated Lyme disease might respond slowly or incompletely, and more than one antibiotic treatment course can be required in some cases 1, 8
  • Additional antibiotic therapy is not recommended for patients with persistent symptoms following standard treatment but lacking objective evidence of active infection 5, 4
  • Previous Lyme disease does not ensure protective immunity, and antibodies often persist for months or years after successfully treated infection 1, 9

Special Considerations

  • For Lyme arthritis with minimal response to initial oral antibiotics, a 2-4 week course of IV ceftriaxone is suggested, as recommended by the American College of Rheumatology 4
  • For patients with refractory Lyme arthritis, anti-inflammatory agents and possibly surgical synovectomy may be needed, according to the Centers for Disease Control and Prevention 1, 4

REFERENCES